Waisman Gabriel sold $1.5M of NVMI

Waisman Gabriel (CEO & President) sold 2,966 shares of NOVA LTD. (NVMI) at $501.30 ($1.49M total) on 2026-07-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Waisman Gabriel
Published Jul 6, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 7:48 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NVMI
Neutral
high confidence
Mentioned
$NVMI
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NVMINeutralLow
01

Why it matters

Traders may monitor insider activity for sentiment, but 10b5-1 plans generally reduce interpretability as a forward-looking signal.

02

Market read

A CEO open-market sale of about $1.49M is disclosed, but the 10b5-1 structure suggests limited fundamental implications.

03

What to watch

The article provides no context on total holdings changes beyond the post-transaction figure, and no link to performance or upcoming events.

Relevance 5/10Novelty 3/10Timing: filed 2026-07-06, sale dated 2026-07-02

Background

The article is an SEC Form 4 insider transaction disclosure for NOVA Ltd. (NVMI).

Company-level read

Ticker impact

$NVMINeutralHigh confidence
Context

Form 4 shows CEO Gabriel Waisman sold 2,966 shares of NVMI at $501.30 on 2026-07-02 under a 10b5-1 plan.

Expected impact

Likely limited near-term impact; any effect is more about sentiment than fundamentals.

Evidence & confidence

The filing is an open-market sale by the CEO, explicitly under a pre-arranged 10b5-1 plan, with no accompanying guidance, deal, or regulatory action.

Market effects

No clear sector read-through from a single 10b5-1 insider sale.

None indicated.

None indicated.

Counterpoint

Insider sales under 10b5-1 can be purely liquidity-driven and may not signal reduced confidence.

Key entities

  • NOVA Ltd.

    Company subject of the Form 4 insider transaction disclosure.

  • Waisman Gabriel

    CEO and President who executed an open-market sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NVMIMed

Nova Q3 Earnings Call Highlights

Nova (NVMI) reported strong Q3 results, with record advanced packaging sales and significant demand for its WMC platform. Logic and foundry accounted for 61% of product revenue. The company forecasted Q4 revenue of $305M-$315M and expects GAAP EPS of $2.78-$2.94. Nova ended Q3 with $1.8B in cash and repurchased $38.5M of shares. It plans to discuss future strategy at an investor day in March 2027.

$NVMIMed

Nova Ltd (NVMI) Q3 2026 Earnings Call Highlights: Record Revenue, $1 Billion Milestone

Nova Ltd (NVMI) reported record Q3 2026 revenue, reaching $1 billion. The company faces supply chain constraints and expects new competition in materials metrology. Gross margin is guided to remain flat at 59%. Operating expenses are expected to increase in Q4 2026 due to higher R&D spending. CEO Gabriel Waisman highlighted growth opportunities in memory and gate-all-around metrology, with strong demand for the Metrion tool despite longer lead times.

$NVMIHighAI 8/10

Nova (NVMI) Q3 2026 Earnings Call Transcript

Nova (NVMI) reported Q3 2026 revenue of $287.8M, up 13% QoQ and 28% YoY, driven by strong demand in memory, advanced packaging, and logic segments. The company expects to exceed $1B in annual revenue, a year ahead of plan. Q4 guidance projects revenue between $305M-$315M and EPS between $2.78-$2.94 (GAAP) and $3.03-$3.18 (non-GAAP).